JP2005530735A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005530735A5 JP2005530735A5 JP2003585723A JP2003585723A JP2005530735A5 JP 2005530735 A5 JP2005530735 A5 JP 2005530735A5 JP 2003585723 A JP2003585723 A JP 2003585723A JP 2003585723 A JP2003585723 A JP 2003585723A JP 2005530735 A5 JP2005530735 A5 JP 2005530735A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- medicament
- warm
- creating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 claims 16
- 241001465754 Metazoa Species 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- 230000005865 ionizing radiation Effects 0.000 claims 3
- 230000001093 anti-cancer Effects 0.000 claims 2
- 230000000259 anti-tumor effect Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 230000002792 vascular Effects 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0208680A GB0208680D0 (en) | 2002-04-16 | 2002-04-16 | Combination therapy |
| GB0218388A GB0218388D0 (en) | 2002-08-08 | 2002-08-08 | Combination therapy |
| PCT/GB2003/001617 WO2003088971A1 (en) | 2002-04-16 | 2003-04-14 | Combination therapy for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005530735A JP2005530735A (ja) | 2005-10-13 |
| JP2005530735A5 true JP2005530735A5 (https=) | 2006-05-11 |
Family
ID=29252451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003585723A Pending JP2005530735A (ja) | 2002-04-16 | 2003-04-14 | 癌の処置のための併用療法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20050215530A1 (https=) |
| EP (1) | EP1496909B1 (https=) |
| JP (1) | JP2005530735A (https=) |
| KR (1) | KR20040103964A (https=) |
| CN (1) | CN100352441C (https=) |
| AT (1) | ATE353650T1 (https=) |
| AU (1) | AU2003216558B2 (https=) |
| BR (1) | BR0309226A (https=) |
| CA (1) | CA2482591A1 (https=) |
| DE (1) | DE60311788T2 (https=) |
| ES (1) | ES2280735T3 (https=) |
| IL (1) | IL164564A0 (https=) |
| MX (1) | MXPA04010166A (https=) |
| NO (1) | NO20044498L (https=) |
| NZ (1) | NZ535739A (https=) |
| WO (1) | WO2003088971A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0218526D0 (en) * | 2002-08-09 | 2002-09-18 | Astrazeneca Ab | Combination therapy |
| WO2004112801A2 (en) * | 2003-06-18 | 2004-12-29 | Angiogene Pharmaceuticals Limited | Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer |
| KR100872204B1 (ko) * | 2003-10-15 | 2008-12-09 | 오에스아이 파마슈티컬스, 인코포레이티드 | 이미다조피라진 티로신 키나제 억제제 |
| TWI378934B (en) * | 2004-04-02 | 2012-12-11 | Osi Pharm Inc | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| BRPI0510657A (pt) | 2004-06-03 | 2007-12-04 | Hoffmann La Roche | tratamento com cisplatina e com um inibidor de egfr |
| BRPI0511754A (pt) * | 2004-06-03 | 2008-01-02 | Smithkline Beechman Cork Ltd | uso de um composto ou sais ou solvatos do mesmo |
| US20060084666A1 (en) * | 2004-10-18 | 2006-04-20 | Harari Paul M | Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor |
| FR2886151B1 (fr) * | 2005-05-31 | 2007-09-07 | Mayoly Spindler Soc Par Action | Utilisation de la colchicine pour la preparation d'un medicament destine a la prevention et/ou au traitement de l'endometriose |
| US8575164B2 (en) * | 2005-12-19 | 2013-11-05 | OSI Pharmaceuticals, LLC | Combination cancer therapy |
| JP2011510018A (ja) * | 2008-01-18 | 2011-03-31 | オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド | 癌治療のためのイミダゾピラジノール誘導体 |
| EP2283020B8 (en) * | 2008-05-19 | 2012-12-12 | OSI Pharmaceuticals, LLC | Substituted imidazopyr-and imidazotri-azines |
| EP2408479A1 (en) | 2009-03-18 | 2012-01-25 | OSI Pharmaceuticals, LLC | Combination cancer therapy comprising administration of an egfr inhibitor and an igf-1r inhibitor |
| WO2010123792A1 (en) | 2009-04-20 | 2010-10-28 | Osi Pharmaceuticals, Inc. | Preparation of c-pyrazine-methylamines |
| EP2427192A1 (en) * | 2009-05-07 | 2012-03-14 | OSI Pharmaceuticals, LLC | Use of osi-906 for treating adrenocortical carcinoma |
| WO2012129145A1 (en) | 2011-03-18 | 2012-09-27 | OSI Pharmaceuticals, LLC | Nscle combination therapy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU661533B2 (en) * | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
| GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| GB9714249D0 (en) * | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| EE200200565A (et) * | 2000-03-31 | 2004-06-15 | Angiogene Pharmaceuticals Ltd. | Vaskulaarse kahjustava toimega kombinatsioonravi |
| GB0008269D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
-
2003
- 2003-04-14 DE DE60311788T patent/DE60311788T2/de not_active Expired - Fee Related
- 2003-04-14 JP JP2003585723A patent/JP2005530735A/ja active Pending
- 2003-04-14 BR BR0309226-7A patent/BR0309226A/pt not_active IP Right Cessation
- 2003-04-14 EP EP03712464A patent/EP1496909B1/en not_active Expired - Lifetime
- 2003-04-14 MX MXPA04010166A patent/MXPA04010166A/es active IP Right Grant
- 2003-04-14 AU AU2003216558A patent/AU2003216558B2/en not_active Ceased
- 2003-04-14 CN CNB03813702XA patent/CN100352441C/zh not_active Expired - Fee Related
- 2003-04-14 KR KR10-2004-7016666A patent/KR20040103964A/ko not_active Ceased
- 2003-04-14 AT AT03712464T patent/ATE353650T1/de not_active IP Right Cessation
- 2003-04-14 WO PCT/GB2003/001617 patent/WO2003088971A1/en not_active Ceased
- 2003-04-14 CA CA002482591A patent/CA2482591A1/en not_active Abandoned
- 2003-04-14 ES ES03712464T patent/ES2280735T3/es not_active Expired - Lifetime
- 2003-04-14 US US10/511,744 patent/US20050215530A1/en not_active Abandoned
- 2003-04-14 NZ NZ535739A patent/NZ535739A/en unknown
-
2004
- 2004-10-13 IL IL16456404A patent/IL164564A0/xx unknown
- 2004-10-21 NO NO20044498A patent/NO20044498L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006504723A5 (https=) | ||
| JP2005511597A5 (https=) | ||
| IL171683A (en) | Immunosuppressive Compounds, Medicinal Products Containing Them and Their Use in the Preparation of Medication for Treatment | |
| JP2005530735A5 (https=) | ||
| JP2006500346A5 (https=) | ||
| IL184051A (en) | Acetylated GLP-1 compounds, containing and using pharmaceutical preparations | |
| IL213597A0 (en) | Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments | |
| IL165532A (en) | History of Aryl Carbonyl, Pharmaceutical Preparations Containing Them and Their Use in the Preparation of Medicines for the Treatment of Metabolic Disorders | |
| IL231576A (en) | Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines | |
| CL2008001932A1 (es) | Compuestos derivados de 6-cicloamino-3-(piridin-4-il)imidazo[1,2-b]piridazina, inhibidores de cq1epsilon y/o ck1delta; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso en el tratamiento de desordenes del sueno, trastorno del ritmo circadiano, cancer y enfermedad de alzheimer. | |
| IL164373A (en) | Benzamide derivatives, pharmaceutical compositions containing them, process for their preparation and use thereof in the manufacture of medicaments and as medicaments in the treatment of diseases associated with cancer | |
| IL179714A (en) | Pharmaceutical preparation containing a history of 2-biphenyl-4-ram-3,2-dehydro-1h-quinazoline-4-on and its use in the preparation of cancer drugs and blood vessel formation | |
| EP1635762A4 (en) | LOW-DOSED PHARMACEUTICAL POWDER FOR INHALATION | |
| CL2003002287A1 (es) | COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS | |
| IL201176A (en) | 4-amino-1-h-pyrazolo [3,4- d] pyrimidine-3-ram-phenyl, a pharmaceutical containing them and their use in the preparation of a drug | |
| IL191984A0 (en) | Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer | |
| JP2012524089A5 (https=) | ||
| IL209879A0 (en) | Substituted pteridines ,pharmaceutical compositions containing them and their use in the manufacture of medicaments for treating inflammatory diseases | |
| WO2006050155A3 (en) | Cancer therapeutic compositions | |
| WO2006053049A3 (en) | Herbal composition phy906 and its use in chemotherapy | |
| JP2008514577A5 (https=) | ||
| DE69215999D1 (de) | Therapeutische Mittel für die Behandlungder Resistenz gegen Arzneimittel bei Krebs | |
| JP2015507020A5 (https=) | ||
| IL187575A (en) | Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders | |
| NO20044498L (no) | Kombinasjonsterapi for behandling av cancer |